“Co-administration of an insulin secretagogue such as glibenclamide (Glib) along with GABA may enhance the pancreatic insulin output in T1D.”
“ GABA and Glib (5 mg/kg) combination therapy achieved far better control over hyperglycaemia and related pathogenic conditions (b.w.,”
“ GABA and Glib synergistically augmented insulin secretion that can be used to manage T1D and its complications.”
“ GABA has the potential to remarkably enhance the therapeutic outcome in diabetic patients and reduce the dose of existing anti-diabetic drugs such as Glib.”